Molecular mechanism of miRNA regulating PD-L1 expression

被引:0
|
作者
Zhao, Wenxin [1 ,2 ]
Li, Xiaolan [1 ,2 ]
Ren, Qunli [1 ,2 ]
Wang, Qian [1 ,2 ]
Liao, Chengcheng [2 ]
Ding, Tianhao [2 ]
Li, Ping [1 ]
Liu, Jianguo [2 ]
机构
[1] Zunyi Med Univ, Microbial Resources & Drug Dev Key Lab Guizhou Ter, Sch Stomatol, Zunyi 563000, Peoples R China
[2] Zunyi Med Univ, Sch Clin Med, Zunyi 563000, Peoples R China
来源
GENE REPORTS | 2023年 / 31卷
关键词
PD-L1; miRNA; Immune checkpoint; Molecular regulation; Tumor suppressor gene; BREAST-CANCER; TARGETS PD-L1;
D O I
10.1016/j.genrep.2023.101763
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
PD-L1 (programmed death-ligand 1) binding to PD-1 (programmed cell death protein 1) reduces the proliferation of PD-1-positive cells, inhibits their cytokine secretion, and induces apoptosis. miRNA (microRNA) as an important regulator of gene expression, affects the performance of gene function. Similarly, the expression of PDL1 is also regulated by miRNA. miRNAs usually negatively regulate gene expression, however, is there positive regulation? We reviewed the molecular mechanisms of the positive and negative regulation of PD-L1 expression by miRNAs. miRNAs mainly indirectly and positively regulate PD-L1 expression through the regulation of tumor suppressor genes PTEN (phosphatase and tensin homolog) and LATS2 (large tumor suppressor kinase 2), oncogene YAP1 (Yes1 associated transcriptional regulator), DNA damage response protein Ku80 (80-kilodalton subunit of the Ku heterodimer protein), etc., while negative regulation is mainly achieved by miRNAs directly binding to the 3 & PRIME;-UTR (3 & PRIME; untranslated region) of PD-L1 mRNA. And this negative regulation can also be reversed by the negative regulation of miRNAs by RNA-binding protein LIN28 (protein lin-28) or circRNAs (circular RNA) such as cire0000284 and circ-CPA4. The revealing of this mechanism provides more references and strategies for immune checkpoint therapy of tumors.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Investigating the molecular mechanism underlying PD-L1 expression after DNA damage for precision radioimmunotherapy
    Shibata, Atsushi
    CANCER SCIENCE, 2018, 109 : 1213 - 1213
  • [22] Small molecule PD-L1 inhibitor modulates expression of PD-L1 on the cell surface - a potential mechanism of blocking interaction with PD-1
    Weitsman, G.
    Chan, J. Nuo En
    Nedbal, J.
    Barber, P. R.
    Volgina, A.
    Stevens, C.
    Poland, S.
    Ameer-Beg, S.
    Suhling, K.
    Rios-Doria, J.
    Ng, T.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S70 - S70
  • [23] Cimetidine enhances PD-1 blockade efficacy in melanoma by regulating PD-L1 expression on tumor
    Lee, B.
    Kim, D.
    Lee, B.
    Lee, J.
    Shin, K.
    Kim, H.
    Ko, H.
    Kim, B.
    Kim, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S217 - S217
  • [24] PD-L1 expression in pancreatic adenosquamous carcinoma: PD-L1 expression is limited to the squamous component
    Tanigawa, Masahiko
    Naito, Yoshiki
    Akiba, Jun
    Kawahara, Akihiko
    Okabe, Yoshinobu
    Ishida, Yusuke
    Ishikawa, Hiroto
    Hisaka, Toru
    Fujita, Fumihiko
    Yasunaga, Masafumi
    Shigaki, Takahiro
    Sudo, Tomoya
    Mihara, Yutaro
    Nakayama, Masamichi
    Kondo, Reiichiro
    Kusano, Hironori
    Shimamatsu, Kazuhide
    Okuda, Koji
    Akagi, Yoshito
    Yano, Hirohisa
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (12) : 2069 - 2074
  • [25] PD-L1 expression in different molecular subgroups of endometrial carcinomas
    Evsei, A.
    Birceanu, A.
    Copca, N.
    Dumitru, A.
    Sajin, M.
    VIRCHOWS ARCHIV, 2020, 477 : S63 - S63
  • [26] PD-L1 Protein Expression and PD-L1 Gene Amplification in Breast Cancer
    Voronel, Olga
    Dalvi, Siddhartha
    Kallakury, Bhaskar Vs
    Sheehan, Christine E.
    Boguniewicz, Ann B.
    Ross, Jeffrey S.
    LABORATORY INVESTIGATION, 2016, 96 : 77A - 77A
  • [27] Development of small-molecular-based radiotracers for PET imaging of PD-L1 expression and guiding the PD-L1 therapeutics
    Hongzhang Yang
    Xinying Zeng
    Jia Liu
    Xuejun Wen
    Huanhuan Liu
    Yuanyuan Liang
    Xueqi Wang
    Jianyang Fang
    Qinglin Zhang
    Jindian Li
    Xianzhong Zhang
    Zhide Guo
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1582 - 1592
  • [28] PD-L1 and PD1 Expression in Lymphomas
    Gatalica, Zoran
    Bilalovic, Nurija
    Vranic, Semir
    Arguello, David
    Reddy, Sandeep
    Ghosh, Nilanjan
    BLOOD, 2015, 126 (23)
  • [29] PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival
    Micevic, Goran
    Thakral, Durga
    McGeary, Meaghan
    Bosenberg, Marcus W.
    PIGMENT CELL & MELANOMA RESEARCH, 2019, 32 (03) : 435 - 440
  • [30] PD-L1 Protein Expression and PD-L1 Gene Amplification in Breast Cancer
    Voronel, Olga
    Dalvi, Siddhartha
    Kallakury, Bhaskar V. S.
    Sheehan, Christine E.
    Boguniewicz, Ann B.
    Ross, Jeffrey S.
    MODERN PATHOLOGY, 2016, 29 : 77A - 77A